spacer
home > pmps > autumn 2003 > generics boards surfing the new wave in contract manufacturing services
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Generics Boards Surfing the New Wave in Contract Manufacturing Services

With the rapidly rising tide in sales of unbranded medicines, are the holders of expiring patents for branded products about to find themselves stranded on the rocks or simply getting wet feet?

Recent developments at the WTO and changes in Europe's pharmaceutical legislation could drive suppliers of generics to outsource development and production to countries like Portugal, where they can take the necessary steps before the tide turns for their branded or innovator competition.

With about 35 per cent of pharma's lucrative blockbusters coming off patent by 2007, the rising tide of generics will experience a big surge driving the managerial boards of generics suppliers to get to market as early as possible, preferably as soon as the bell-buoy rings 'time up'.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Patricia Lobo, Editor of PMPS and Associate Director at Technomark Consulting Services Limited

Patricia Lobo PhD, Associate Director and Senior Consultant at Technomark Consulting Services Ltd, is the Editor of Pharmaceutical Manufacturing and Packing Sourcer (PMPS) published by Samedan Ltd. Patricia has worked for over 25 years in the pharmaceutical industry in quality control, clinical research, marketing and business development. Since she joined Technomark in 1992, Patricia has developed considerable expertise and a first class reputation in the core business of outsourcing clinical trials, and in contract manufacturing and packaging, providing in-depth market reports and strategic planning advice to a wide range of pharma and biotech companies.

spacer
Dr Patricia Lobo
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals and Nordic Nanovector have extended partnership for Betalutin® late stage manufacturing for B-cell non-Hodgkin lymphoma (NHL) treatment

The non-Hodgkin lymphoma (NHL) is a cancer that starts in white blood cells called lymphocytes, which are part of the body’s immune system
More info >>

White Papers

Speciality Logistics Outlook 2015

World Courier

To date, there are more than 178,000 registered clinical trials taking place across the globe, and global pharma’s volume has more than doubled over the last decade. With emerging markets showing explosive predictive growth through 2016, shippers and trial sponsors can expect continued regulatory and overall logistics complexities that foster demand for local, inmarket resources across the globe.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement